• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移植候补维持性血液透析患者的体重指数和体重减轻与死亡率的关系。

Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients.

机构信息

Harold Simmons Center for Chronic Disease Research and Epidemiology, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.

出版信息

Am J Transplant. 2011 Apr;11(4):725-36. doi: 10.1111/j.1600-6143.2011.03468.x.

DOI:10.1111/j.1600-6143.2011.03468.x
PMID:21446975
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3074356/
Abstract

A body mass index (BMI) below morbid obesity range is often a requirement for kidney transplant wait-listing, but data linking BMI changes to mortality during the waitlist period are lacking. By linking the 6-year (7/2001-6/2007) national databases of a large dialysis organization and the Scientific Registry of Transplant Recipients, we identified 14 632 waitlisted hemodialysis patients without kidney transplantation. Time-dependent survival models examined the mortality predictability of 13-week-averaged BMI, pretransplant serum creatinine as a muscle mass surrogate and their changes over time. The patients were on average 52 ± 13 years old, 40% women and had a BMI of 26.9 ± 6.3 kg/m². Each kg/m² increase of BMI was associated with a death hazard ratio (HR) of 0.96 (95%CI: 0.95-0.97). Compared to the lowest creatinine quintile, the 4th and 5th quintiles had death HRs of 0.75 (0.66-0.86) and 0.57 (0.49-0.66), respectively. Compared to minimal (< ± 1 kg) weight change over 6 months, those with 3 kg- < 5 kg and ≥ 5 kg weight loss had death HRs of 1.31 (1.14-1.52) and 1.51 (1.30-1.75), respectively. Similar associations were observed with creatinine changes over time. Transplant-waitlisted hemodialysis patients with lower BMI or muscle mass and/or unintentional weight or muscle loss have higher mortality in this observational study. Impact of intentional weight change remains unclear.

摘要

身体质量指数(BMI)低于病态肥胖范围通常是肾移植候补名单的要求,但缺乏将 BMI 变化与候补期间死亡率相关联的数据。通过将大型透析组织的 6 年(2001 年 7 月-2007 年 6 月)国家数据库与移植受者科学登记处相链接,我们确定了 14632 名未接受肾移植的候补血液透析患者。时间依赖性生存模型检查了 13 周平均 BMI、移植前血清肌酐作为肌肉质量替代物及其随时间变化的死亡率预测能力。患者平均年龄为 52 ± 13 岁,40%为女性,BMI 为 26.9 ± 6.3kg/m²。BMI 每增加 1kg/m²,死亡风险比(HR)为 0.96(95%CI:0.95-0.97)。与肌酐最低五分位数相比,第 4 五分位数和第 5 五分位数的死亡 HR 分别为 0.75(0.66-0.86)和 0.57(0.49-0.66)。与 6 个月期间体重变化最小(<±1kg)相比,体重减轻 3kg-<5kg 和≥5kg 的死亡 HR 分别为 1.31(1.14-1.52)和 1.51(1.30-1.75)。随着时间的推移,肌酐变化也观察到类似的关联。在这项观察性研究中,BMI 或肌肉量较低且/或非故意体重或肌肉损失的移植候补血液透析患者死亡率较高。有意改变体重的影响仍不清楚。

相似文献

1
Associations of body mass index and weight loss with mortality in transplant-waitlisted maintenance hemodialysis patients.移植候补维持性血液透析患者的体重指数和体重减轻与死亡率的关系。
Am J Transplant. 2011 Apr;11(4):725-36. doi: 10.1111/j.1600-6143.2011.03468.x.
2
Associations of pretransplant weight and muscle mass with mortality in renal transplant recipients.移植前体重和肌肉量与肾移植受者死亡率的关系。
Clin J Am Soc Nephrol. 2011 Jun;6(6):1463-73. doi: 10.2215/CJN.09131010. Epub 2011 Mar 17.
3
Trajectory of Lean Body Mass Assessed Using the Modified Creatinine Index and Mortality in Hemodialysis Patients.使用改良肌酐指数评估的瘦体重轨迹与血液透析患者的死亡率。
Am J Kidney Dis. 2020 Feb;75(2):195-203. doi: 10.1053/j.ajkd.2019.05.034. Epub 2019 Sep 26.
4
[REIN Report 2011--summary].[2011年肾脏疾病改善全球结果(KDIGO)报告——摘要]
Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1.
5
A "weight-listing" paradox for candidates of renal transplantation?肾移植候选者的“体重清单”悖论?
Am J Transplant. 2007 Mar;7(3):550-9. doi: 10.1111/j.1600-6143.2006.01629.x. Epub 2006 Dec 6.
6
Survival in patients on hemodialysis: Effect of gender according to body mass index and creatinine.血液透析患者的生存:根据体重指数和肌酐的性别影响。
PLoS One. 2018 May 16;13(5):e0196550. doi: 10.1371/journal.pone.0196550. eCollection 2018.
7
Association of body weight changes with mortality in incident hemodialysis patients.体重变化与新进入血液透析患者死亡率的相关性。
Nephrol Dial Transplant. 2017 Sep 1;32(9):1549-1558. doi: 10.1093/ndt/gfw373.
8
Mortality prediction by surrogates of body composition: an examination of the obesity paradox in hemodialysis patients using composite ranking score analysis.利用身体成分替代指标预测死亡率:采用综合排序评分分析检查血液透析患者的肥胖悖论。
Am J Epidemiol. 2012 Apr 15;175(8):793-803. doi: 10.1093/aje/kwr384. Epub 2012 Mar 16.
9
Serum Creatinine Modifies Associations between Body Mass Index and Mortality and Morbidity in Prevalent Hemodialysis Patients.血清肌酐改变了维持性血液透析患者体重指数与死亡率和发病率之间的关联。
PLoS One. 2016 Mar 1;11(3):e0150003. doi: 10.1371/journal.pone.0150003. eCollection 2016.
10
Pre-Transplant Weight Loss and Survival after Kidney Transplantation.肾移植前体重减轻与肾移植后的生存率
Am J Nephrol. 2015;41(6):448-55. doi: 10.1159/000437341. Epub 2015 Jul 25.

引用本文的文献

1
Obesity measurement methods estimated mortality risk in patients undergoing hemodialysis: a systematic review and meta-analysis.肥胖测量方法对接受血液透析患者死亡风险的估计:一项系统评价和荟萃分析。
Int Urol Nephrol. 2025 May;57(5):1585-1600. doi: 10.1007/s11255-024-04312-1. Epub 2024 Dec 11.
2
Treatment of Type 2 Diabetes Mellitus in Advanced Chronic Kidney Disease for the Primary Care Physician.基层医疗医生对晚期慢性肾脏病患者2型糖尿病的治疗
Cureus. 2024 Jul 16;16(7):e64663. doi: 10.7759/cureus.64663. eCollection 2024 Jul.
3
Weight change in chronic kidney disease: Association with mortality and kidney function.慢性肾脏病中的体重变化:与死亡率及肾功能的关联
Obes Sci Pract. 2023 Nov 22;10(1):e723. doi: 10.1002/osp4.723. eCollection 2024 Feb.
4
Obesity is Associated With Delayed Graft Function in Kidney Transplant Recipients: A Paired Kidney Analysis.肥胖与肾移植受者移植物功能延迟有关:配对肾脏分析。
Transpl Int. 2023 May 30;36:11107. doi: 10.3389/ti.2023.11107. eCollection 2023.
5
[Unintentional weight loss in chronic kidney disease].[慢性肾脏病中的非故意体重减轻]
Inn Med (Heidelb). 2023 Jun;64(6):532-539. doi: 10.1007/s00108-023-01527-9. Epub 2023 May 23.
6
Combined Donor-Recipient Obesity and the Risk of Graft Loss After Kidney Transplantation.供受者肥胖合并与肾移植后移植物丢失的风险。
Transpl Int. 2022 Sep 29;35:10656. doi: 10.3389/ti.2022.10656. eCollection 2022.
7
Modifiable Lifestyle Behaviors and CKD Progression: A Narrative Review.可改变的生活方式行为与慢性肾脏病进展:一个叙述性综述。
Kidney360. 2022 Jan 14;3(4):752-778. doi: 10.34067/KID.0003122021. eCollection 2022 Apr 28.
8
Obesity Management in Kidney Transplant Candidates: Current Paradigms and Gaps in Knowledge.肾移植候选人的肥胖管理:当前知识的范例和差距。
Adv Chronic Kidney Dis. 2021 Nov;28(6):528-541. doi: 10.1053/j.ackd.2021.09.009.
9
Obesity, Weight Loss, Lifestyle Interventions, and Autosomal Dominant Polycystic Kidney Disease.肥胖、体重减轻、生活方式干预与常染色体显性多囊肾病
Kidney Dial. 2022 Mar;2(1):106-122. doi: 10.3390/kidneydial2010013. Epub 2022 Mar 4.
10
Low muscle mass and early hospital readmission post-kidney transplantation.肌肉量低与肾移植后早期再入院。
Int Urol Nephrol. 2022 Aug;54(8):1977-1986. doi: 10.1007/s11255-021-03085-1. Epub 2022 Jan 14.

本文引用的文献

1
The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis.接受血液透析患者的肥胖悖论和与身体大小及肌肉质量替代指标相关的死亡率。
Mayo Clin Proc. 2010 Nov;85(11):991-1001. doi: 10.4065/mcp.2010.0336.
2
Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients.上臂中部肌肉周长与维持性血液透析患者的生活质量和生存率。
Clin J Am Soc Nephrol. 2010 Dec;5(12):2258-68. doi: 10.2215/CJN.02080310. Epub 2010 Oct 14.
3
Survival predictability of lean and fat mass in men and women undergoing maintenance hemodialysis.男性和女性维持性血液透析患者瘦体质量和脂肪质量的生存预测能力。
Am J Clin Nutr. 2010 Nov;92(5):1060-70. doi: 10.3945/ajcn.2010.29188. Epub 2010 Sep 15.
4
Sleep disorders, depressive symptoms and health-related quality of life--a cross-sectional comparison between kidney transplant recipients and waitlisted patients on maintenance dialysis.睡眠障碍、抑郁症状与健康相关生活质量——维持性透析的肾移植受者与候补患者的横断面比较。
Nephrol Dial Transplant. 2011 Mar;26(3):1058-65. doi: 10.1093/ndt/gfq476. Epub 2010 Aug 4.
5
Kidney and pancreas transplantation in the United States, 1999-2008: the changing face of living donation.美国 1999-2008 年的肾和胰腺移植:活体捐献者的变化。
Am J Transplant. 2010 Apr;10(4 Pt 2):987-1002. doi: 10.1111/j.1600-6143.2010.03022.x.
6
Pre-transplant overweight and obesity do not affect physical quality of life after kidney transplantation.移植前超重和肥胖不会影响肾移植后的身体生活质量。
J Am Coll Surg. 2010 Mar;210(3):336-44. doi: 10.1016/j.jamcollsurg.2009.11.009. Epub 2010 Feb 1.
7
Association of hemodialysis treatment time and dose with mortality and the role of race and sex.血液透析治疗时间和剂量与死亡率的关系及种族和性别的作用。
Am J Kidney Dis. 2010 Jan;55(1):100-12. doi: 10.1053/j.ajkd.2009.08.007. Epub 2009 Oct 22.
8
Obesity, surgical site infection, and outcome following renal transplantation.肥胖、手术部位感染与肾移植术后转归
Ann Surg. 2009 Dec;250(6):1014-20. doi: 10.1097/SLA.0b013e3181b4ee9a.
9
Abdominal obesity and all-cause and cardiovascular mortality in end-stage renal disease.腹型肥胖与终末期肾病患者的全因死亡率和心血管死亡率
J Am Coll Cardiol. 2009 Apr 14;53(15):1265-72. doi: 10.1016/j.jacc.2008.12.040.
10
Predictors of hyporesponsiveness to erythropoiesis-stimulating agents in hemodialysis patients.血液透析患者对促红细胞生成素反应低下的预测因素
Am J Kidney Dis. 2009 May;53(5):823-34. doi: 10.1053/j.ajkd.2008.12.040. Epub 2009 Apr 1.